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Abstract: Introduction: Need for procedural sedation and analgesia (PSA) is felt in emergency department (ED) more
and more each day. This study aimed to compare the effectiveness of low-dose fentanyl, propofol, midazolam,
ketamine and lidocaine combination with regular dose of propofol and fentanyl combination for induction of
deep sedation. Methods: In this single-blind clinical trial, candidate patients for sedation and analgesia aged
more than 15 and less than 60 years old, with pain score ≥6 were allocated to one of the groups using block
randomization and were compared regarding onset of action, recovery time, and probable side effects. Results:
125 patients with the mean age of 37.8 ± 14.3 years were randomly allocated to each group. 100% of the patients
in group 1 (5 drugs) and 56.5% of the patients in group 2 (2 drugs) were deeply sedated in the 3rd minute after
injection. The 2 groups were significantly different regarding onset of action (p = 0.440), recovery time (p =
0.018), and treatment failure (p < 0.001). Conclusion: Low-dose fentanyl, propofol, midazolam, ketamine and
lidocaine combination was more successful in induction of deep sedation compared to regular dose of propofol
and fentanyl combination. Recovery time was a little longer in this group and both groups were similar regarding
drug side effects and effect on vital signs.
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1. Introduction
Pain and excessive agitation are usually big obstacles for pro-
viding medical services (1, 2). Therefore, need for procedural
sedation and analgesia (PSA) is felt in emergency department
(ED) more and more each day. It is estimated that 10% of ED
patients need some kind of sedative (3-5). PSA is a technique
used to induce a level of anesthesia and analgesia for pa-
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tients in order to undergo unpleasant and painful procedures
without changes in cardiopulmonary function. Drugs used
for sedation induction can be classified in 2 general groups
of sedatives such as propofol, ketamine, etomidate, and mi-
dazolam and analgesics such as fentanyl, remifentanil, mor-
phine, and ketamine (6). These drugs have the potential for
causing dangerous side effects such as respiratory, cardiac
and vascular depression, especially in higher doses (7). Find-
ing new compounds that have few side effects in addition to
effective and deep PSA with rapid recovery of patients from
PSA is of great interest. Numerous studies have evaluated
and compared drug compounds. Both propofol-ketamine
and propofol-fentanyl have provided sufficient sedation and
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analgesia during dressing change for burn patients (8). Both
compounds have also provided sufficient analgesia for do-
ing endoscopy of the upper digestive system but propofol-
ketamine compound has led to more stable hemodynamics
and deeper analgesia (9). Using low-dose drugs can prevent
manifestation of drug side effects. However, there is no accu-
rate data regarding the effects of using low-dose sedative and
analgesic drugs. Therefore, this study aimed to compare the
effectiveness and safety of using low-dose sedative and anal-
gesic drugs (including propofol, ketamine, midazolam, fen-
tanyl, and lidocaine) with regular dose of propofol and fen-
tanyl in patients in need of PSA presenting to ED.
2. Methods
2.1. Study design and setting
The present study is a clinical trial carried out aiming to com-
pare the effectiveness of low-dose 5 drug combination (fen-
tanyl, propofol, midazolam, ketamine, and lidocaine) with
regular dose of 2 drug combination (propofol-fentanyl) for
induction of deep sedation in patients presenting to the ED
of Imam Hossein Teaching Hospital, during 6 months in
2015. In line with the Declaration of Helsinki, the researchers
adhered to ethical principles and kept patient data confiden-
tial. Before entering the study, all participants were given
explanations regarding the study protocol and then writ-
ten informed consent was obtained from them. The pro-
tocol of the study was registered on the Iranian registry of
clinical trials under the number IRCT2015112525235N1 and
was approved by the ethics committee of Shahid Beheshti
University of Medical Sciences under the license number:
sbmu.rec.13930717.
2.2. Participants
In this study, candidate patients for PSA, according to the de-
cision of a senior emergency medicine specialist, whose age
was over 15 and under 60 years and had a pain score equal
to or higher than 7 (based on numeric analog scale: NAS)
were included. In cases of patients not wanting to partici-
pate, previous allergy to drugs used in the study, allergy to
protein products such as egg and soy, hemodynamic insta-
bility, increased intracranial pressure and lactating and preg-
nant women, they were excluded.
2.3. Intervention
In this study, patients were randomly allocated to 2 groups
via block randomization. Group 1 consisted of patients
receiving a low-dose fentanyl (0.5 -1 µg/kg), propofol (0.5
mg/kg), midazolam (0.1–0.02 mg/kg), ketamine (0.2–0.25
mg/kg), and lidocaine (0.5 mg/kg) combination and group
2 included patients receiving regular dose of propofol (1
mg/kg) and fentanyl (1 mg/kg). Drug injection was done
during 20 - 30 seconds using syringes with a similar volume
and color. All the patients were under close cardiac, respi-
ratory, blood pressure, and blood O2 saturation monitoring
during the procedure. Time interval between receiving drug
and deep PSA induction was considered as the drug’s onset
of action. In addition, the time interval between deep PSA
and complete recovery was considered as recovery time. For
measuring pain severity, NAS was used and for measuring
depth of PSA, Ramsay system was applied. Ramsey score of 6
was considered as deep PSA and score of 2 was considered as
recovery. Pain score equal to or higher than 6 was considered
severe pain.
2.4. Data gathering
To gather data, a checklist consisting of demographic data
(age, sex, weight); vital signs (blood pressure, respiratory rate,
heart rate, O2 saturation) before and during procedure; rea-
son for requiring PSA (upper/lower limb injury, soft tissue in-
jury); and final studied outcome (onset of drug action, re-
covery time, probable side effects, and patient and physi-
cian’s satisfaction) was designed and used. Data gathering
was done by a senior emergency medicine resident in charge
of carrying out the study. Patients and data analyzer were
blind to the administered drugs.
2.5. Outcome
Onset of action and recovery time were considered as pri-
mary outcomes and drug side effects such as nausea and
vomiting, apnea and hemodynamic instability in addition
to patient and physician’s satisfaction were considered sec-
ondary outcomes.
2.6. Statistical Analysis
Considering 17 minutes standard deviation in recovery time,
5% error, 10% desired precision, and 90% power, the mini-
mum sample size required for each group was estimated to
be 61 cases (10). Data were analyzed using SPSS 20. Quali-
tative variables were reported as frequency and percentage,
and quantitative ones as mean ± standard deviation. Chi
squared and Fisher’s exact tests were applied for analytical
comparisons. Non-parametric test of chi-square for trend
was used for evaluating the frequency of successful PSA cases
and assessing recovery time. Significance level was consid-
ered to be p < 0.05.
3. Results
3.1. Baseline characteristics
125 patients with the mean age of 37.8 ± 14.3 (15-60) years
were studied (75.2% male). 63 (50.4%) patients were ran-
domly allocated to group 1 and 62 (49.6%) to group 2. Table 1
compares the baseline characteristics of the studied patients.
This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0).
Downloaded from: www.jemerg.com
3 Emergency. 2018; 6 (1): e57
Table 1: Baseline characteristics of the studied patients
Variable Group 1 (n = 63) Group 2 (n = 62) P
Sex
Male 45 (71.4) 46 (74.2) 0.80
Female 18 (28.6) 16 (25.8)
Age (year)
Mean ± standard deviation 37.2 ± 13.2 38.2 ± 15.6 0.70
Weight (kg)
Mean ± standard deviation 73.4 ± 12.4 70.1 ± 11.1 0.12
History of PSA*
No 56 (91.8) 54 (87.1) 0.40
Yes 5 (8.2) 8 (12.9)
Reason for requiring PSA*
Upper limb injury 45 (71.4) 44 (71.0)
Lower limb injury 15 (23.8) 16 (25.8) 0.99
Soft tissue injury 1 (1.6) 1 (1.6)
Other 2 (3.2) 1 (1.6)
History of underlying illness
Yes 5 (8.2) 8 (12.9) 0.29
No 58 (92.1) 54 (87.1)
Vital signs
Heart rate (/minute) 84.5 ± 11.6 88.0 ± 11.2 0.09
Respiratory rate (/minute) 15.6 ± 1.8 16.1 ± 1.9 0.23
Systolic blood pressure (mmHg) 123.4 ± 12.0 124.8 ± 12.7 0.52
Diastolic blood pressure (mmHg) 79.9 ± 9.4 79.3 ± 19.6 0.73
Arterial O2 saturation (%) 97.3 ± 1.6 98.3 ± 13.3 0.63
PSA: procedural sedation and analgesia; Data are shown as mean ± standard deviation or frequency (%).
Figure 1: Kaplan-Meier curve of recovery time (in minutes) for the
2 studied groups.
The 2 groups were not significantly different regarding demo-
graphic data.
3.2. Comparison of outcomes
Table 2 compares the outcome of treatment in the 2 groups.
The 2 groups were significantly different regarding onset of
action (p = 0.440), recovery time (p = 0.018), treatment failure
(p < 0.001), physician’s satisfaction (p < 0.001), and patient’s
satisfaction (p < 0.001). Kaplan-Meier curve of recovery time
for the 2 studied groups is shown in figure 1. 100% of the pa-
tients in group 1 and 56.5% of the patients in group 2 were
deeply sedated in the 3rd minute after injection. In total, 5
cases of side effect due to PSA were detected that included
3 (2.4%) vertigo and 2 (1.6%) vomiting cases. The cost of the
treatment regimen for a 70-kg patient was 33750 Rials (1.7 US
dollar) in group 2 (2 drug combination) and 37400 Rials (1.9
US Dollar) in group 1 (5 drug combination).
4. Discussion
Based on the findings of the present study, low-dose propo-
fol, ketamine, midazolam, fentanyl, and lidocaine combina-
tion had a higher success rate in inducing deep sedation,
and patient and physician’s satisfaction compared to fentanyl
and propofol combination with regular dose. Recovery time
in this group was slightly longer and the 2 groups did not
differ significantly regarding drug side effects and influence
on vital signs. As mentioned before, finding new drugs that
have few side effects in addition to effective and deep PSA
with rapid recovery is of great interest among physicians. In
line with the current study, Ebrahimi et al. aimed to com-
pare propofol-midazolam and propofol-fentanyl regimens
in patients undergoing microlaryngeal surgery and showed
that mean arterial O2 saturation during laryngoscopy was
further reduced in fentanyl group, while recovery time was
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Table 2: Comparison of treatment characteristics between low-dose multi-drug group (group 1) and propofol-fentanyl combination group
(group 2)
Variable Group 1 Group 2 P
Onset of action (minute)
Mean ± standard deviation 1.73 ± 0.62 1.36 ± 1.29 0.044
Treatment failure
Number (%) 0 (0) 22 (37.1) < 0.001
Recovery time (minute)
Mean ± standard deviation 6.48 ± 1.84 5.02 ± 4.47 0.03
Vital signs
Heart rate (/minute) 78.2 ± 8.8 83.1 ± 9.8 0.006
Systolic blood pressure (mmHg) 119.0 ± 12.1 121.0 ± 11.6 0.36
Diastolic blood pressure (mmHg) 74.8 ± 9.0 76.25 ± 9.7 0.73
Arterial O2 saturation (%) 95.5 ± 3.1 91.9 ± 6.8 0.00003
Side effects
None 61 (96.8) 59 (95.2)
Vertigo 1 (1.6) 2 (3.2) 0.836
Vomiting 1 (1.6) 1 (1.6)
Patient’s satisfaction
Dissatisfied 1 (1.6) 1 (1.6)
Partial 19 (30.2) 56 (90.3) < 0.001
Complete 43 (68.3) 5 (8.1)
Physician’s satisfaction
Dissatisfied 1 (1.6) 1 (1.6)
Partial 19 (30.2) 53 (86.9) < 0.001
Complete 43 (68.3) 7 (11.5)
Data are shown as mean ± standard deviation or frequency (%).
shorter in midazolam group (11). Comparison of propofol-
ketamine and propofol-fentanyl compounds for PSA induc-
tion in pediatric burn patients during change of dressing
showed that there is no significant difference between these
combinations regarding heart rate, systolic blood pressure,
arterial O2 saturation, respiratory rate, and sedation score
during PSA (8). Erden et al. showed that adding a low
dose of ketamine to propofol-fentanyl combination leads
to decreased risk of drop in arterial O2 saturation and less
need for additional propofol for induction of analgesia (12).
Using propofol-ketamine combination results in more sta-
ble hemodynamics and deeper analgesia in PSA induction
for pediatrics during upper gastrointestinal tract endoscopy
compared to propofol-fentanyl. However, it had more side
effects (9). Akin et al. also revealed that propofol-fentanyl
and propofol-ketamine groups had no significant difference
regarding analgesia during endometrial biopsy (13). As can
be seen, most studies expressed that combination of propo-
fol and ketamine or propofol and midazolam are better reg-
imens for PSA induction compared to propofol-fentanyl.
Other observations emphasize that ketamine is a safe drug
and a proper sedative for use in EDs (14). The advantage of
the present study over other similar ones is using low doses
of multiple sedatives for PSA induction. Most study proto-
cols have been based on using 2 or at most 3 drugs, while this
study designed a 5-drug protocol. Confirmation of the re-
sults of the current study requires carrying out further studies
with stronger methodologies and considering different racial
characteristics.
5. Limitation
The study being single-blind is among the most important
limitations of this study.
6. Conclusion
Based on the findings of the present study, low-dose fentanyl,
propofol, midazolam, ketamine and lidocaine combination
was more successful in induction of deep sedation compared
to regular dose of propofol and fentanyl combination and
was associated with higher satisfaction among both patients
and physicians. Recovery time was a little longer in this group
and the 2 groups were not significantly different regarding
drug side effects and effect on vital signs.
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